MGNX - MacroGenics crashes after mid-stage data for prostate cancer drug
2024-05-10 08:03:03 ET
More on MacroGenics
- MacroGenics, Inc. (MGNX) Q1 2024 Earnings Call Transcript
- MacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024
- MacroGenics, Inc. (MGNX) Q4 2023 Earnings Call Transcript
- MacroGenics GAAP EPS of -$0.84 misses by $0.19, revenue of $9.1M misses by $5.76M
- MacroGenics Q1 2024 Earnings Preview